COVID‐19 and preeclampsia: The unique and the mutually nonexclusive clinical manifestations.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13700
- By:
- Publication type:
- Article
Works matching IS 10467408 AND DT 2023 AND VI 89 AND IP 5
Results: 6
1
2
The association of race and ethnicity on obstetric patients' COVID‐19 outcomes: A summary of current literature.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13698
- By:
- Publication type:
- Article
3
Expression of inflammatory, angiogenic, and extracellular matrix‐related mediators in the cervicovaginal fluid of women with preterm premature rupture of membranes: Relationship with acute histological chorioamnionitis.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13697
- By:
- Publication type:
- Article
4
The Tpl2‐MEK pathway plays a critical role in spheroid‐cultured endometriotic stromal cells.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13689
- By:
- Publication type:
- Article
5
Hsa_circ_0001326 inhibited the proliferation, migration, and invasion of trophoblast cells via miR‐145‐5p/TGFB2 axis.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13682
- By:
- Publication type:
- Article
6
Issue Information.
- Published in:
- American Journal of Reproductive Immunology, 2023, v. 89, n. 5, p. 1, doi. 10.1111/aji.13569
- Publication type:
- Article